Merck says its HPV vaccine for men was approved by China's drug regulator
The Hindu
Merck's HPV vaccine for males aged 9-26 approved in China, announced on social media.
U.S. drugmaker Merck & Co said on Wednesday (January 8, 2025) that its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration.
The vaccine has been cleared to be used for males aged 9-26 years, according to Merck's statement on Chinese social media.
OpenAI CEO Sam Altman denied that he sexually abused his sister, calling all of her allegations of abuse against him and his family “untrue.”
Anita Anand emerges as frontrunner to replace Justin Trudeau, poised to make history as Canada's first woman of color Prime Minister.
Fast-moving wildfires break out in Los Angeles, destroying homes and prompting evacuations as residents flee in chaos.
Over 2.1 million displaced in Burkina Faso face violence, discrimination, and neglect, challenging the military junta's stability narrative.
UN reports soaring gang violence in Haiti, with over 5,600 dead in 2024, highlighting need for urgent action.
Impeached South Korean President Yoon Suk Yeol's residence transformed into fortress amid arrest attempts and political crisis.
Merck's HPV vaccine for males aged 9-26 approved in China, announced on social media.
Shooting in Bad Friedrichshall leaves two dead, one injured; police searching for masked perpetrator in Germany.
Rescue efforts underway after deadly quake in Tibet, with hundreds saved and thousands of homes destroyed.
Las Vegas police reveal soldier used AI to plan Tesla Cybertruck explosion, intended as a wake-up call.
Seaplane crash off Rottnest Island leaves three seriously injured and three missing, sparking investigation by aviation authorities.